Bobotik - instructions for use, analogs, reviews and release forms (drops for ingestion) of a drug for the treatment of colic and flatulence in adults, children (including infants and newborns) and during pregnancy. Composition

In this article, you can read the instructions for using the drug Bobotik. Presented are reviews of visitors to the site - consumers of this medication, as well as opinions of doctors specialists on the use of Bobotik in their practice. A big request is to actively add their feedback on the drug: the medicine helped or did not help get rid of the disease, which were observed complications and side effects, possibly not declared by the manufacturer in the annotation. Bobotik analogues in the presence of existing structural analogues. Use to treat colic and flatulence in adults, children (including infants and newborns),as well as during pregnancy and lactation. Composition of the preparation.

Bobotik - a drug that reduces flatulence. Simethicone (activated dimethicone - the active substance of the drug Bobotik) is a combination of methylated linear siloxane polymers stabilized with trimethylsiloxyl groups from silicon dioxide. Reducing the surface tension at the interface, complicates the formation and contributes to the destruction of gas bubbles in the contents of the intestine and mucus of the gastrointestinal tract. The gases released in this way can be absorbed by the walls of the intestine or removed by peristalsis. This prevents the formation of large gas-mucous conglomerates, causing a painful swelling of the abdomen.

When sonogram and radiography prevents the occurrence of image defects; promotes better irrigation of the mucous membrane of the colon with contrast agents, preventing the rupture of the contrast film.

Due to chemical inertness does not affect the microorganisms and enzymes present in the gastrointestinal tract. Does not reduce the absorption of food, does not change the reaction and the volume of gastric juice.

Composition

Emulsion of simethicone 30% + Simethicone + auxiliary substances.

Pharmacokinetics

Simethicone after ingestion is not absorbed from the digestive tract and is excreted through the intestine in unchanged form.

Indications

• increased gas formation and accumulation of gases in the digestive tract (colic, a feeling of filling in the abdominal cavity, flatulence (including in the postoperative period), Remgeld's syndrome, aerophagia);
• preparation for diagnostic studies of the abdominal and pelvic organs (radiography, sonography, gastroscopy and duodenoscopy - to prevent the formation of foam).

Forms of release

Drops for oral administration.

Instructions for use and dosage

The drug is prescribed inside, after eating.

Before use, the vial should be shaken until a uniform emulsion is obtained.

For accurate dosing of the drug during instillation, the bottle should be held vertically.

With increased gassing and accumulation of gases in the GIT, children from 28 days of life to 2 years (infants and newborns) are prescribed 8 drops (20 mg simethicone) 4 times a day; children from 2 to 6 years - 14 drops (35 mg simethicone) 4 times a day; children over 6 years and adults - 16 drops (40 mg simethicone) 4 times a day.

For a more convenient administration of the drug, in particular to small children, it can be premixed with a small amount of cold boiled water, baby food or non-carbonated liquid.

After the disappearance of symptoms, the drug should be discontinued.

When preparing for diagnostic procedures (radiography of the digestive tract) 1 day before the study, the drug is prescribed 2 times a day (morning and evening): children from 28 days of life to 2 years - 10 drops (25 mg), children from 2 to 6 years - 16 drops (40 mg), children older than 6 years and adults - 20 drops (50 mg).

For sonographic examination of the digestive tract 1 day before the study, the drug is prescribed 2 times a day (in the morning and in the evening) in the dosages recommended in preparation for radiographic examination. 3 hours before the start of the study, the dose should be repeated.

Side effect

• possible the development of allergic reactions.

Contraindications

• intestinal obstruction;
• obstructive diseases of the digestive tract;
• newborns until the 28th day of life;
• hypersensitivity to simethicone and / or other components of the drug.

Application in pregnancy and lactation

In pregnancy, the use of the drug is possible only in those cases,when the intended use for the mother exceeds the potential risk to the fetus.

There are no data on the safety of the drug in lactating women. During the period of breastfeeding the child, the drug should be used only if necessary.

Use in children

The drug is contraindicated for newborns until the 28th day of life.

special instructions

The drug does not contain sugar, it is possible to use patients with diabetes and digestive disorders.

During the treatment it is not recommended to take carbonated drinks.

Admission of the drug may distort the results of some diagnostic tests, for example, a test using guaiac resin.

Impact on the ability to drive vehicles and manage mechanisms

The drug does not affect the driving of vehicles and maintenance of mechanical devices.

Drug Interactions

The bobotik can cause a violation of absorption of oral anticoagulants.

Analogues of the drug Bobotik

Structural analogs for the active substance:

• Antiflat Lannacher;
• Diflatil;
• Meteopazmil;
• Sub simplex;
• Simethicone;
• Simikol;
• Espumizan;
• Espumizan 40;
• Espumizan L.

Similar medicines:

Other medicines: